{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,24]],"date-time":"2024-08-24T01:10:21Z","timestamp":1724461821553},"reference-count":15,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nursing for Women's Health"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1111\/j.1751-486x.2011.01668.x","type":"journal-article","created":{"date-parts":[[2011,10,31]],"date-time":"2011-10-31T16:27:17Z","timestamp":1320078437000},"page":"431-434","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Oral Contraception: New Options"],"prefix":"10.1016","volume":"15","author":[{"given":"Jeanne M.","family":"Wilton","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1111\/j.1751-486X.2011.01668.x_bb0010","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.contraception.2009.03.018","article-title":"Bleeding pattern and cycle control with an estradiol-based oral contraceptive: A seven-cycle, randomized comparative trial of estradiol valerate\/dienogest and ethinyl estradiol\/levonorgestrel","volume":"80","author":"Ahrendt","year":"2009","journal-title":"Contraception"},{"issue":"5","key":"10.1111\/j.1751-486X.2011.01668.x_bb0015","first-page":"8","article-title":"Big step forward and downward: An OC with 10 mcg of estrogen","volume":"23","author":"Barbieri","year":"2011","journal-title":"OBG Management"},{"year":"2011","series-title":"Product information for Beyaz","author":"Bayer HealthCare Pharmaceuticals, Inc.","key":"10.1111\/j.1751-486X.2011.01668.x_bb0020"},{"issue":"4","key":"10.1111\/j.1751-486X.2011.01668.x_bb0025","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1097\/AOG.0b013e318212b333","article-title":"Oral contraceptives and heavy periods","volume":"117","author":"Drife","year":"2011","journal-title":"Obstetrics and Gynecology"},{"author":"Food and Drug Administration","key":"10.1111\/j.1751-486X.2011.01668.x_bb0030"},{"year":"2007","key":"10.1111\/j.1751-486X.2011.01668.x_bb0035","article-title":"Contraceptive Technology"},{"issue":"10","key":"10.1111\/j.1751-486X.2011.01668.x_bb0040","doi-asserted-by":"crossref","first-page":"697","DOI":"10.7326\/0003-4819-143-10-200511150-00006","article-title":"Trends in the incidence of venous thromboembolism during pregnancy or postpartum: A 30-year population-based study","volume":"143","author":"Heit","year":"2005","journal-title":"Annals of Internal Medicine"},{"author":"Hitt","key":"10.1111\/j.1751-486X.2011.01668.x_bb0045"},{"issue":"12","key":"10.1111\/j.1751-486X.2011.01668.x_bb0050","first-page":"69","article-title":"Women's health","volume":"17","year":"2010","journal-title":"Prescribers Letter"},{"issue":"7","key":"10.1111\/j.1751-486X.2011.01668.x_bb0055","article-title":"Natazia","volume":"17","year":"2010","journal-title":"Prescribers Letter"},{"issue":"4","key":"10.1111\/j.1751-486X.2011.01668.x_bb0060","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1097\/AOG.0b013e3182118ac3","article-title":"Effective treatment of heavy menstrual bleeding with estradiol valerate and dienogest: A randomized controlled trial","volume":"117","author":"Jensen","year":"2011","journal-title":"Obstetrics and Gynecology"},{"issue":"5","key":"10.1111\/j.1751-486X.2011.01668.x_bb0065","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.contraception.2008.11.011","article-title":"Adding low-dose estrogen to the hormone-free interval: Impact on bleeding patterns in users of a 91-day extended regimen oral contraceptive","volume":"79","author":"Kaunitz","year":"2009","journal-title":"Contraception"},{"issue":"1","key":"10.1111\/j.1751-486X.2011.01668.x_bb0070","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.contraception.2007.09.010","article-title":"Effects on serum hormone levels of low-dose estrogen in place of placebo during the hormone-free interval of an oral contraceptive","volume":"77","author":"Reape","year":"2008","journal-title":"Contraception"},{"key":"10.1111\/j.1751-486X.2011.01668.x_bb0075","doi-asserted-by":"crossref","first-page":"626","DOI":"10.7326\/0003-4819-150-9-200905050-00009","article-title":"Folic acid for the prevention of neural tube defects: U.S. Preventive Services Task Force recommendation statement","volume":"150","author":"U.S. Preventive Services Task Force","year":"2009","journal-title":"Annals of Internal Medicine"},{"year":"2010","series-title":"Product information for Lo Loestrin Fe","author":"Warner Chilcott","key":"10.1111\/j.1751-486X.2011.01668.x_bb0080"}],"container-title":["Nursing for Women's Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1751485115306073?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1751485115306073?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,24]],"date-time":"2024-08-24T00:03:21Z","timestamp":1724457801000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1751485115306073"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":15,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S1751485115306073"],"URL":"https:\/\/doi.org\/10.1111\/j.1751-486x.2011.01668.x","relation":{},"ISSN":["1751-4851"],"issn-type":[{"type":"print","value":"1751-4851"}],"subject":[],"published":{"date-parts":[[2011,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oral Contraception: New Options","name":"articletitle","label":"Article Title"},{"value":"Nursing for Women's Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/j.1751-486X.2011.01668.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 AWHONN. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}